FDA Approves Another Generic Abortion Pill

Conservative politicians and pro-life groups criticized the move.

The U.S. Food and Drug Administration (FDA) in White Oak, Md., on June 5, 2023. Madalina Vasiliu/The Epoch Times

Food and Drug Administration officials have approved another generic variety of the abortion drug mifepristone.

In a letter dated Sept. 30, the FDA said it had approved Evita Solutions’ generic version of Danco Laboratories’ mifepristone.